[Systemic therapy for hepatocellular carcinoma: from molecular targeted agent to combined immunotherapy]

Nihon Shokakibyo Gakkai Zasshi. 2023;120(1):46-55. doi: 10.11405/nisshoshi.120.46.
[Article in Japanese]
No abstract available

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Combined Modality Therapy
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / drug therapy
  • Molecular Targeted Therapy

Substances

  • Antineoplastic Agents